Unity Biotechnology Unveils Mixed Data From Study For Diabetes-Related Blindness, Stock Falls

All NewsMarch 24, 2025

Unity diabetes study showing durable vision gains with full 36-week data expected in Q2 2025.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent